Priority-setting for obesity prevention-The Assessing Cost-Effectiveness of obesity prevention policies in Australia (ACE-Obesity Policy) study.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 23 01 2020
accepted: 02 06 2020
entrez: 20 6 2020
pubmed: 20 6 2020
medline: 2 9 2020
Statut: epublish

Résumé

The aim of the ACE-Obesity Policy study was to assess the economic credentials of a suite of obesity prevention policies across multiple sectors and areas of governance for the Australian setting. The study aimed to place the cost-effectiveness results within a broad decision-making context by providing an assessment of the key considerations for policy implementation. The Assessing Cost-Effectiveness (ACE) approach to priority-setting was used. Systematic literature reviews were undertaken to assess the evidence of intervention effectiveness on body mass index and/or physical activity for selected interventions. A standardised evaluation framework was used to assess the cost-effectiveness of each intervention compared to a 'no intervention' comparator, from a limited societal perspective. A multi-state life table Markov cohort model was used to estimate the long-term health impacts (quantified as health adjusted life years (HALYs)) and health care cost-savings resulting from each intervention. In addition to the technical cost-effectiveness results, qualitative assessments of implementation considerations were undertaken. All 16 interventions evaluated were found to be cost-effective (using a willingness-to-pay threshold of AUD50,000 per HALY gained). Eleven interventions were dominant (health promoting and cost-saving). The incremental cost-effectiveness ratio for the non-dominant interventions ranged from AUD1,728 to 28,703 per HALY gained. Regulatory interventions tended to rank higher on their cost-effectiveness results, driven by lower implementation costs. However, the program-based policy interventions were generally based on higher quality evidence of intervention effectiveness. This comparative analysis of the economic credentials of obesity prevention policies for Australia indicates that there are a broad range of policies that are likely to be cost-effective, although policy options vary in strength of evidence for effectiveness, affordability, feasibility, acceptability to stakeholders, equity impact and sustainability. Implementation of these policies will require sustained co-ordination across jurisdictions and multiple government sectors in order to generate the predicted health benefits for the Australian population.

Identifiants

pubmed: 32559212
doi: 10.1371/journal.pone.0234804
pii: PONE-D-20-02180
pmc: PMC7304600
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0234804

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

JMIR Mhealth Uhealth. 2014 Aug 21;2(3):e37
pubmed: 25147135
Int J Behav Nutr Phys Act. 2008 Sep 10;5:45
pubmed: 18782458
Lancet. 2011 Aug 27;378(9793):826-37
pubmed: 21872751
Pediatrics. 2014 Apr;133(4):e868-74
pubmed: 24590749
Lancet Diabetes Endocrinol. 2013 Oct;1(2):97-105
pubmed: 24349967
Lancet. 2016 Oct 8;388(10053):1659-1724
pubmed: 27733284
PLoS One. 2017 Oct 11;12(10):e0184799
pubmed: 29020093
PLoS Med. 2017 Jun 27;14(6):e1002326
pubmed: 28654688
Nutrients. 2020 Feb 26;12(3):
pubmed: 32110864
BMJ. 2013 Mar 25;346:f1049
pubmed: 23529982
Pharmacoeconomics. 2001;19(11):1103-9
pubmed: 11735677
Lancet. 2010 Nov 20;376(9754):1775-84
pubmed: 21074255
Lancet. 2011 Aug 27;378(9793):804-14
pubmed: 21872749
Pharmacoeconomics. 1998 Apr;13(4):397-409
pubmed: 10178664
Med Sci Sports Exerc. 2011 Aug;43(8):1575-81
pubmed: 21681120
Lancet. 2012 Dec 15;380(9859):2129-43
pubmed: 23245605
Int J Environ Res Public Health. 2014 Apr 14;11(4):4007-25
pubmed: 24736685
Obes Rev. 2009 Jan;10(1):76-86
pubmed: 18761640
BMC Public Health. 2016 Oct 13;16(1):1084
pubmed: 27737707
J Epidemiol Community Health. 2010 Mar;64(3):209-12
pubmed: 19692711
Int J Obes (Lond). 2020 May;44(5):1011-1020
pubmed: 31792336
Int J Obes (Lond). 2019 May;43(5):1102-1112
pubmed: 30926947
Expert Rev Pharmacoecon Outcomes Res. 2008 Dec;8(6):593-617
pubmed: 20528370
Nutrients. 2018 May 15;10(5):
pubmed: 29762517
Scand J Work Environ Health. 2018 Sep 1;44(5):503-511
pubmed: 30078034
Nutrients. 2017 Sep 06;9(9):
pubmed: 28878175
Int J Obes (Lond). 2006 Oct;30(10):1463-75
pubmed: 17003807
BMC Public Health. 2009 Nov 18;9:419
pubmed: 19922625
Obes Rev. 2005 Feb;6(1):23-33
pubmed: 15655036
Nutrients. 2018 May 14;10(5):
pubmed: 29757979
BMC Public Health. 2017 May 4;17(1):359
pubmed: 28468618
Aust N Z J Public Health. 2010 Jun;34(3):240-7
pubmed: 20618263
Curr Obes Rep. 2020 Jun;9(2):150-158
pubmed: 32266649
Health Promot J Austr. 2018 Jul;29 Suppl 1:7-9
pubmed: 29667784
JAMA. 2013 Aug 14;310(6):591-608
pubmed: 23842577
Lancet. 2017 Dec 16;390(10113):2627-2642
pubmed: 29029897

Auteurs

Jaithri Ananthapavan (J)

Deakin Health Economics, School of Health and Social Development, Institute for Health Transformation, Deakin University, Geelong, Australia.
Global Obesity Centre, School of Health and Social Development, Institute for Health Transformation, Deakin University, Geelong, Australia.

Gary Sacks (G)

Global Obesity Centre, School of Health and Social Development, Institute for Health Transformation, Deakin University, Geelong, Australia.

Vicki Brown (V)

Deakin Health Economics, School of Health and Social Development, Institute for Health Transformation, Deakin University, Geelong, Australia.
Global Obesity Centre, School of Health and Social Development, Institute for Health Transformation, Deakin University, Geelong, Australia.

Marj Moodie (M)

Deakin Health Economics, School of Health and Social Development, Institute for Health Transformation, Deakin University, Geelong, Australia.
Global Obesity Centre, School of Health and Social Development, Institute for Health Transformation, Deakin University, Geelong, Australia.

Phuong Nguyen (P)

Deakin Health Economics, School of Health and Social Development, Institute for Health Transformation, Deakin University, Geelong, Australia.
Global Obesity Centre, School of Health and Social Development, Institute for Health Transformation, Deakin University, Geelong, Australia.

Lennert Veerman (L)

School of Medicine, Griffith University, Gold Coast, Australia.

Ana Maria Mantilla Herrera (AM)

Queensland Centre for Mental Health Research, Brisbane, Australia.
School of Public Health, The University of Queensland, Brisbane, Australia.
Institute for Health Metrics and Evaluation, University of Washington, Seattle, Washington, United States of America.

Anita Lal (A)

Deakin Health Economics, School of Health and Social Development, Institute for Health Transformation, Deakin University, Geelong, Australia.
Global Obesity Centre, School of Health and Social Development, Institute for Health Transformation, Deakin University, Geelong, Australia.

Anna Peeters (A)

Global Obesity Centre, School of Health and Social Development, Institute for Health Transformation, Deakin University, Geelong, Australia.

Rob Carter (R)

Deakin Health Economics, School of Health and Social Development, Institute for Health Transformation, Deakin University, Geelong, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH